Crossmark

Gastrointestinal neuroendocrine tumor with discordant metastatic disease on 111In-pentetreotide SPECT/CT, 18F-DOPA PET/CT and 68Ga-HA-DOTATATE PET/CT

Published Online: 2022-07-04

Published Print: 2022-12

Authors

Resch, Katrin

Hung, Ryan

Abele, Jonathan
License Information

Text and Data Mining valid from 2022-07-04

Version of Record valid from 2022-07-04
More Information

Article History

Received: 5 January 2022

Accepted: 31 March 2022

First Online: 4 July 2022

Declarations

:

: Not applicable.

: The authors have no financial or non-financial interests to disclose.

Document is current